chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Client received 1st dose of Pfizer vaccine on 2/5/21.  Client received 2nd dose of Pfizer vaccine on 2/27/21.  Client developed COVID symptoms on 4/18/21 and had a confirmed positive COVID (rapid test) test on 4/20/21.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Deep vein thrombosis, Full blood count, Metabolic function test, Muscle spasms, Platelet count decreased
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Swelling, Thrombocytopenia, Ultrasound Doppler abnormal
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time shortened, Angiogram pulmonary abnormal, Anticoagulant therapy, Antiphospholipid antibodies, Antithrombin III
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood homocysteine normal, Blood smear test, C-reactive protein increased, Chest pain, Coagulation test normal
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Deep vein thrombosis, Electrocardiogram normal, Fibrin D dimer increased, Full blood count
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Haptoglobin, Limb discomfort, Myalgia, Pain in extremity, Platelet count decreased
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet factor 4, Platelet morphology, Protein C, Protein S, Pulmonary embolism
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Red blood cell sedimentation rate normal, Thrombophlebitis superficial, Ultrasound Doppler abnormal, Venous occlusion
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Chest discomfort, Deep vein thrombosis, Heparin-induced thrombocytopenia test positive, Immunoglobulin therapy
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Platelet count decreased, Pulmonary embolism
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Angiogram, Antiphospholipid antibodies, Beta-2 glycoprotein antibody, Blood fibrinogen
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood homocysteine, Blood magnesium, C-reactive protein, Cardiolipin antibody, Cell marker increased
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram thorax, Deep vein thrombosis, Electrocardiogram, Factor II mutation, Factor V Leiden mutation
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fibrin D dimer, Full blood count, Haematocrit, Haemoglobin, Headache
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Heparin-induced thrombocytopenia test, Hypercoagulation, Magnetic resonance imaging head, Mean cell haemoglobin concentration, Mean cell volume
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Metabolic function test, Muscle spasms, Oxygen saturation, Pain in extremity, Platelet count
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Platelet factor 4, Prothrombin level, Pulmonary embolism, Red blood cell count
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Red blood cell sedimentation rate, SARS-CoV-2 test, Smear test, Swelling, Thrombocytopenia
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Ultrasound Doppler, Ultrasound Doppler abnormal, Vital signs measurement, White blood cell count
Clinical narrative: CONFIRMED VITT CASE.  The patient presented with leg pain and chest discomfort, and was hospitalized and found to have low platelets (74) and acute DVT and Pulmonary embolism. He was started on empiric treatment for VITT, including IVIG, steroids, and argatroban,  and the anti-PF4 resulted as OD = 2.9 (strong positive), confirming the diagnosis. He is recovering well.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: Patient complained of throat swelling and itching shortly after receiving first dose of Moderna, denied shortness of breath or hives. EMT responded; Vitals stable, alert and oriented, lungs clear, no hives apparent.  Transported to ER via ambulance. Complained of itchiness en route to hospital.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal swelling, Pruritus, Throat irritation
Clinical narrative: Patient complained of throat swelling and itching shortly after receiving first dose of Moderna, denied shortness of breath or hives. EMT responded; Vitals stable, alert and oriented, lungs clear, no hives apparent.  Transported to ER via ambulance. Complained of itchiness en route to hospital.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Accident, Injury
Clinical narrative: bad injury; he can't take the second today; he was not able to go because he was in the hospital this weekend and was released yesterday; This is a spontaneous report from a Pfizer sponsored program . A contactable male consumer (patient). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown), via an unspecified route of administration, on 23Mar2021, as single dose for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. On 13Apr2021, the patient could not take second dose. He wants to reschedule his second dose. In Apr2021, the patient had bad injury and he was not able to go because he was in the hospital on weekend and was released 13Apr2021. on Apr2021. the patient was hospitalized for the event injury. Outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Injury, Product dose omission issue
Clinical narrative: bad injury; he can't take the second today; he was not able to go because he was in the hospital this weekend and was released yesterday; This is a spontaneous report from a Pfizer sponsored program . A contactable male consumer (patient). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown), via an unspecified route of administration, on 23Mar2021, as single dose for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. On 13Apr2021, the patient could not take second dose. He wants to reschedule his second dose. In Apr2021, the patient had bad injury and he was not able to go because he was in the hospital on weekend and was released 13Apr2021. on Apr2021. the patient was hospitalized for the event injury. Outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Kidney infection
Clinical narrative: might have bladder or kidney infection; might have bladder or kidney infection; blood in her urine; She felt like she had to urinate but only a few drops of urine would come out; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number ER8727), via an unspecified route of administration administered in the right arm on 25Mar2021 11:15 at a single dose for covid-19 immunisation. Medical history reported as follows: The patient has had trouble with her bladder since 2008 when she had a bladder sling put in. The patient stated that the company knew there were problems with the bladder slings, and they were still allowing the bladder slings to be put inside of people. There were times when the patient could not urinate and the bladder sling had to be cut and finally taken out of her. The doctor couldn't remove all the bladder sling because some of the bladder sling grew inside of her body. She had to wear a urinary catheter for months strapped to her leg. She had a back surgery and a doctor messed her up on the left side. Her doctor does manipulations on her back and helps her with her pain. Additionally, she had a bladder infection in Oct2020. The patient's concomitant medications were not reported. There were no prior vaccinations within 4 weeks. The patient received her first dose on 25Mar2021. The patient stated that she had a doctor's appointment for her back (medical history). The night before the appointment she was fine, but on the next day (08Apr2021) it was horrible. While she was there in the appointment, she had a urine test and her doctor found blood in her urine on 08Apr2021. She felt like she had to urinate but only a few drops of urine would come out on 08Apr2021. Her doctor told her that the last time she had a bladder infection was in Oct2020 (medical history). Since she might have a bladder or kidney infection on 08Apr2021, she was prescribed Macrobid 100mg take one every 12 hours for 7 days. She's scheduled to receive her second Covid-19 vaccine tomorrow, 15Apr2021. She wanted to know if the antibiotic will cause any problems with getting the second Covid-19 vaccine. The adverse events required a visit to the physician's office. The outcome of the adverse events was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bacterial pyelonephritis, Blood urine present, Cystitis bacterial, Urine analysis, Urine output decreased
Clinical narrative: might have bladder or kidney infection; might have bladder or kidney infection; blood in her urine; She felt like she had to urinate but only a few drops of urine would come out; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number ER8727), via an unspecified route of administration administered in the right arm on 25Mar2021 11:15 at a single dose for covid-19 immunisation. Medical history reported as follows: The patient has had trouble with her bladder since 2008 when she had a bladder sling put in. The patient stated that the company knew there were problems with the bladder slings, and they were still allowing the bladder slings to be put inside of people. There were times when the patient could not urinate and the bladder sling had to be cut and finally taken out of her. The doctor couldn't remove all the bladder sling because some of the bladder sling grew inside of her body. She had to wear a urinary catheter for months strapped to her leg. She had a back surgery and a doctor messed her up on the left side. Her doctor does manipulations on her back and helps her with her pain. Additionally, she had a bladder infection in Oct2020. The patient's concomitant medications were not reported. There were no prior vaccinations within 4 weeks. The patient received her first dose on 25Mar2021. The patient stated that she had a doctor's appointment for her back (medical history). The night before the appointment she was fine, but on the next day (08Apr2021) it was horrible. While she was there in the appointment, she had a urine test and her doctor found blood in her urine on 08Apr2021. She felt like she had to urinate but only a few drops of urine would come out on 08Apr2021. Her doctor told her that the last time she had a bladder infection was in Oct2020 (medical history). Since she might have a bladder or kidney infection on 08Apr2021, she was prescribed Macrobid 100mg take one every 12 hours for 7 days. She's scheduled to receive her second Covid-19 vaccine tomorrow, 15Apr2021. She wanted to know if the antibiotic will cause any problems with getting the second Covid-19 vaccine. The adverse events required a visit to the physician's office. The outcome of the adverse events was unknown.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Blood test, Hypoaesthesia, Magnetic resonance imaging, Swelling face
Clinical narrative: Bell's palsy; Left wrist felt like it was jammed, stuck, or sprained; Left wrist felt like it was jammed, stuck, or sprained; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID VACCINE, solution for injection, batch/lot number was not reported), dose 1, via an unspecified route of administration, administered in the left arm, on 30Mar2021 11:00 (at the age of 41-years-old) as single dose for COVID-19 immunization. Medical history included thyroid issues diagnosed maybe 7 years ago. The patient has no concomitant medications. The patient reported that she had the first dose and the injection was given in her left arm about 11:00 AM on 30Mar2021, though there were thousands of people there at her appointment at the vaccine center. Around midnight or 01:00 AM on 08Apr2021, the patient woke up with the left side of her face swollen and numb - which was still swollen and numb. The patient can't move the left side of her face. The patient happened to have her neurologist appointment that day, so she brought it to his attention, and he said it was a mild form of Bell's palsy. The patient reported it has gotten worse, it was messing up her speech, she was slurring her words. The patient had a magnetic resonance imaging (MRI) on 13Apr2021, but she doesn't have the results yet. The patient reported that she will start physical therapy and was scheduled to have her blood work on 15Apr2021. The patient also reported that her left hand felt like around the wrist it was like jammed, stuck, or sprained in Apr2021. The outcome of the event Bell's palsy was not recovered while the outcome of the remaining events was unknown.  Information on the lot/batch number has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Joint stiffness, Ligament sprain, Magnetic resonance imaging
Clinical narrative: Bell's palsy; Left wrist felt like it was jammed, stuck, or sprained; Left wrist felt like it was jammed, stuck, or sprained; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID VACCINE, solution for injection, batch/lot number was not reported), dose 1, via an unspecified route of administration, administered in the left arm, on 30Mar2021 11:00 (at the age of 41-years-old) as single dose for COVID-19 immunization. Medical history included thyroid issues diagnosed maybe 7 years ago. The patient has no concomitant medications. The patient reported that she had the first dose and the injection was given in her left arm about 11:00 AM on 30Mar2021, though there were thousands of people there at her appointment at the vaccine center. Around midnight or 01:00 AM on 08Apr2021, the patient woke up with the left side of her face swollen and numb - which was still swollen and numb. The patient can't move the left side of her face. The patient happened to have her neurologist appointment that day, so she brought it to his attention, and he said it was a mild form of Bell's palsy. The patient reported it has gotten worse, it was messing up her speech, she was slurring her words. The patient had a magnetic resonance imaging (MRI) on 13Apr2021, but she doesn't have the results yet. The patient reported that she will start physical therapy and was scheduled to have her blood work on 15Apr2021. The patient also reported that her left hand felt like around the wrist it was like jammed, stuck, or sprained in Apr2021. The outcome of the event Bell's palsy was not recovered while the outcome of the remaining events was unknown.  Information on the lot/batch number has been requested.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Cardiac assistance device user, Cyanosis, Implantable defibrillator insertion, Intensive care
Clinical narrative: cardiac arrest; on the ground turning purple and lifeless/ immediate risk of death from the event; she had no pulse; on the ground turning purple and lifeless; This is a spontaneous report received from a contactable consumer. A 53-year-old female patient (reporter's mother) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN6200), administered in left arm on 24Feb2021 (at the age of 53-year-old) at single dose for COVID-19 immunisation. The vaccination facility type was reported as other. The patient was not pregnant. The patient's medical history was reported as none. No known allergies were reported. The patient had not had COVID prior vaccination. The patient's concomitant medications were not reported. No other vaccine was administered in four weeks. It was reported that on 13Mar2021 08:15 exactly 17 days after reporter's mother received her first Pfizer vaccine she had a cardiac arrest, luckily reporter was with her when this happened and he/she called immediately and followed the steps of cardiopulmonary resuscitation (CPR) etc. When the emergency team arrived she had no pulse and they used the defibrillator on her 4 times. The entire day they did not know if she would survive. She was sedated and tested, they got the news that she had survived and there was not brain damage. The doctors had no clue what the cardiac arrest was caused by, she had no prior health conditions and the tests show nothing to what could have caused this event (no blood clots, no clogged arteries etc.). The only thing that changed leading up to the event was her receiving her first vaccine. Luckily reporter was there when this happened or else she would in fact be dead. She now had a defibrillator implanted and reporter had a post-traumatic stress from the traumatic event and witnessing his/her mom on the ground turning purple and lifeless. They need answers. The events resulted in emergency room/department or urgent care. The events were reported as serious since resulted in hospitalization and life-threatening illness (immediate risk of death from the event). Treatments were received for the events and they were reported as multiple lifesaving treatments, tests, and defibrillator implant. The patient underwent lab tests and procedure which included COVID test (negative) on unspecified date post vaccination. The outcome of the events was resolved for the event "she had no pulse" and resolved with sequel (reported as recovered with lasting effects) for all other events.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulse absent, Resuscitation
Clinical narrative: cardiac arrest; on the ground turning purple and lifeless/ immediate risk of death from the event; she had no pulse; on the ground turning purple and lifeless; This is a spontaneous report received from a contactable consumer. A 53-year-old female patient (reporter's mother) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN6200), administered in left arm on 24Feb2021 (at the age of 53-year-old) at single dose for COVID-19 immunisation. The vaccination facility type was reported as other. The patient was not pregnant. The patient's medical history was reported as none. No known allergies were reported. The patient had not had COVID prior vaccination. The patient's concomitant medications were not reported. No other vaccine was administered in four weeks. It was reported that on 13Mar2021 08:15 exactly 17 days after reporter's mother received her first Pfizer vaccine she had a cardiac arrest, luckily reporter was with her when this happened and he/she called immediately and followed the steps of cardiopulmonary resuscitation (CPR) etc. When the emergency team arrived she had no pulse and they used the defibrillator on her 4 times. The entire day they did not know if she would survive. She was sedated and tested, they got the news that she had survived and there was not brain damage. The doctors had no clue what the cardiac arrest was caused by, she had no prior health conditions and the tests show nothing to what could have caused this event (no blood clots, no clogged arteries etc.). The only thing that changed leading up to the event was her receiving her first vaccine. Luckily reporter was there when this happened or else she would in fact be dead. She now had a defibrillator implanted and reporter had a post-traumatic stress from the traumatic event and witnessing his/her mom on the ground turning purple and lifeless. They need answers. The events resulted in emergency room/department or urgent care. The events were reported as serious since resulted in hospitalization and life-threatening illness (immediate risk of death from the event). Treatments were received for the events and they were reported as multiple lifesaving treatments, tests, and defibrillator implant. The patient underwent lab tests and procedure which included COVID test (negative) on unspecified date post vaccination. The outcome of the events was resolved for the event "she had no pulse" and resolved with sequel (reported as recovered with lasting effects) for all other events.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Heart rate, Investigation, Near death experience, Pulse absent
Clinical narrative: cardiac arrest; on the ground turning purple and lifeless/ immediate risk of death from the event; she had no pulse; on the ground turning purple and lifeless; This is a spontaneous report received from a contactable consumer. A 53-year-old female patient (reporter's mother) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN6200), administered in left arm on 24Feb2021 (at the age of 53-year-old) at single dose for COVID-19 immunisation. The vaccination facility type was reported as other. The patient was not pregnant. The patient's medical history was reported as none. No known allergies were reported. The patient had not had COVID prior vaccination. The patient's concomitant medications were not reported. No other vaccine was administered in four weeks. It was reported that on 13Mar2021 08:15 exactly 17 days after reporter's mother received her first Pfizer vaccine she had a cardiac arrest, luckily reporter was with her when this happened and he/she called immediately and followed the steps of cardiopulmonary resuscitation (CPR) etc. When the emergency team arrived she had no pulse and they used the defibrillator on her 4 times. The entire day they did not know if she would survive. She was sedated and tested, they got the news that she had survived and there was not brain damage. The doctors had no clue what the cardiac arrest was caused by, she had no prior health conditions and the tests show nothing to what could have caused this event (no blood clots, no clogged arteries etc.). The only thing that changed leading up to the event was her receiving her first vaccine. Luckily reporter was there when this happened or else she would in fact be dead. She now had a defibrillator implanted and reporter had a post-traumatic stress from the traumatic event and witnessing his/her mom on the ground turning purple and lifeless. They need answers. The events resulted in emergency room/department or urgent care. The events were reported as serious since resulted in hospitalization and life-threatening illness (immediate risk of death from the event). Treatments were received for the events and they were reported as multiple lifesaving treatments, tests, and defibrillator implant. The patient underwent lab tests and procedure which included COVID test (negative) on unspecified date post vaccination. The outcome of the events was resolved for the event "she had no pulse" and resolved with sequel (reported as recovered with lasting effects) for all other events.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Skin discolouration
Clinical narrative: cardiac arrest; on the ground turning purple and lifeless/ immediate risk of death from the event; she had no pulse; on the ground turning purple and lifeless; This is a spontaneous report received from a contactable consumer. A 53-year-old female patient (reporter's mother) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EN6200), administered in left arm on 24Feb2021 (at the age of 53-year-old) at single dose for COVID-19 immunisation. The vaccination facility type was reported as other. The patient was not pregnant. The patient's medical history was reported as none. No known allergies were reported. The patient had not had COVID prior vaccination. The patient's concomitant medications were not reported. No other vaccine was administered in four weeks. It was reported that on 13Mar2021 08:15 exactly 17 days after reporter's mother received her first Pfizer vaccine she had a cardiac arrest, luckily reporter was with her when this happened and he/she called immediately and followed the steps of cardiopulmonary resuscitation (CPR) etc. When the emergency team arrived she had no pulse and they used the defibrillator on her 4 times. The entire day they did not know if she would survive. She was sedated and tested, they got the news that she had survived and there was not brain damage. The doctors had no clue what the cardiac arrest was caused by, she had no prior health conditions and the tests show nothing to what could have caused this event (no blood clots, no clogged arteries etc.). The only thing that changed leading up to the event was her receiving her first vaccine. Luckily reporter was there when this happened or else she would in fact be dead. She now had a defibrillator implanted and reporter had a post-traumatic stress from the traumatic event and witnessing his/her mom on the ground turning purple and lifeless. They need answers. The events resulted in emergency room/department or urgent care. The events were reported as serious since resulted in hospitalization and life-threatening illness (immediate risk of death from the event). Treatments were received for the events and they were reported as multiple lifesaving treatments, tests, and defibrillator implant. The patient underwent lab tests and procedure which included COVID test (negative) on unspecified date post vaccination. The outcome of the events was resolved for the event "she had no pulse" and resolved with sequel (reported as recovered with lasting effects) for all other events.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aneurysm, Headache, Intensive care
Clinical narrative: HEADACHE,  ACHES/PAINS, CHILLS, NECK PAIN AND STIFFNESS STARTED IN THE PM AFTER THE VACCINE PROGRESSIVELY WORSENED UNTIL UNBEARABLE.  TRANSFERRED FROM ONE HOSPITAL TO ANOTHER FOR SAH. BILATERAL SUPRA CLINOID IC ANEURISM. S/P  CEREBRAL ANGIO, COIL EMBOLIZATION RIGHT SUPRACLINOID ICA. S/P  PIPELINE EMBOLIZATION 4-22-21. DISCHARGED HOME 4-23-21 WITH PT.  FOLLOW UP WITH DR.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aneurysm repair, Angiogram cerebral abnormal, Carotid artery aneurysm, Chills, Headache
Clinical narrative: HEADACHE,  ACHES/PAINS, CHILLS, NECK PAIN AND STIFFNESS STARTED IN THE PM AFTER THE VACCINE PROGRESSIVELY WORSENED UNTIL UNBEARABLE.  TRANSFERRED FROM ONE HOSPITAL TO ANOTHER FOR SAH. BILATERAL SUPRA CLINOID IC ANEURISM. S/P  CEREBRAL ANGIO, COIL EMBOLIZATION RIGHT SUPRACLINOID ICA. S/P  PIPELINE EMBOLIZATION 4-22-21. DISCHARGED HOME 4-23-21 WITH PT.  FOLLOW UP WITH DR.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Intracranial aneurysm, Musculoskeletal stiffness, Neck pain, Pain, Subarachnoid haemorrhage
Clinical narrative: HEADACHE,  ACHES/PAINS, CHILLS, NECK PAIN AND STIFFNESS STARTED IN THE PM AFTER THE VACCINE PROGRESSIVELY WORSENED UNTIL UNBEARABLE.  TRANSFERRED FROM ONE HOSPITAL TO ANOTHER FOR SAH. BILATERAL SUPRA CLINOID IC ANEURISM. S/P  CEREBRAL ANGIO, COIL EMBOLIZATION RIGHT SUPRACLINOID ICA. S/P  PIPELINE EMBOLIZATION 4-22-21. DISCHARGED HOME 4-23-21 WITH PT.  FOLLOW UP WITH DR.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Arteriogram carotid abnormal, Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Hemiparesis
Clinical narrative: Patient presented to the ED with left upper and lower extermity weakness, left upper more so than left lower. He has been having  some weakenss that began the day before, but mostly noticed the symptoms the morning he woke up at 9am. Patient had some transient speech changes which he feels have improved. Symptoms began 12 to 24 hours before presenting to the hospital.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Intensive care, Muscular weakness, Perfusion brain scan abnormal, Speech disorder
Clinical narrative: Patient presented to the ED with left upper and lower extermity weakness, left upper more so than left lower. He has been having  some weakenss that began the day before, but mostly noticed the symptoms the morning he woke up at 9am. Patient had some transient speech changes which he feels have improved. Symptoms began 12 to 24 hours before presenting to the hospital.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Subarachnoid haemorrhage, Superior sagittal sinus thrombosis, Transverse sinus thrombosis
Clinical narrative: Patient presented to the ED with left upper and lower extermity weakness, left upper more so than left lower. He has been having  some weakenss that began the day before, but mostly noticed the symptoms the morning he woke up at 9am. Patient had some transient speech changes which he feels have improved. Symptoms began 12 to 24 hours before presenting to the hospital.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Cerebral venous sinus thrombosis, Cerebrovascular accident, Computerised tomogram head, Computerised tomogram head abnormal
Clinical narrative: Patient presented to the ED with left upper and lower extermity weakness, left upper more so than left lower. He has been having  some weakenss that began the day before, but mostly noticed the symptoms the morning he woke up at 9am. Patient had some transient speech changes which he feels have improved. Symptoms began 12 to 24 hours before presenting to the hospital.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Muscular weakness, NIH stroke scale score increased, Speech disorder, Subarachnoid haemorrhage
Clinical narrative: Patient presented to the ED with left upper and lower extermity weakness, left upper more so than left lower. He has been having  some weakenss that began the day before, but mostly noticed the symptoms the morning he woke up at 9am. Patient had some transient speech changes which he feels have improved. Symptoms began 12 to 24 hours before presenting to the hospital.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Blood thyroid stimulating hormone normal, Brain natriuretic peptide increased, C-reactive protein normal, Chest X-ray abnormal
Clinical narrative: Pulmonary embolism
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Fibrin D dimer increased, Laboratory test abnormal, Lung consolidation, Myocardial strain
Clinical narrative: Pulmonary embolism
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pleural effusion, Pulmonary embolism, Scan with contrast abnormal, Thyroxine free normal
Clinical narrative: Pulmonary embolism
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax, Pulmonary embolism
Clinical narrative: Pulmonary embolism
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: On 4/27/21, client was brought to vaccine site by case manager, who stated that he is homeless and currently at an inpatient psychiatric facility awaiting placement and needed a COVID vaccine in order to get housing. Case manager assisted client fill out Vaccination Screening Form with client signing it. After reviewing answers to questions with client (client denied having been vaccinated previously), Moderna vaccine was administered at 14:45. Client was monitored for the required 15 minute observation, with no adverse effects and stated "I feel fine." Two hours later, after the close of the vaccine clinic, documentation of the vaccine discovered that a previous COVID vaccine dose had been documented on 2/03/21. ThThis dose is recorded as Pfizer 0.3mL EN5318 in the left deltoid at pharmacy. No follow-up dose was recorded, only one dose of Pfizer was recorded. Moderna dose given was recorded into system.  County health services agency vaccination unit was notified for guidance for client safety. Phone calls were not answered, so email was sent with my work cell phone listed. Inpatient facility where client is staying was notified of mixed dose and asked to monitor for any adverse effects. RN on unit stated, "He is sitting in the day room. I just spoke with him and he had no complaints. His vital signs were just taken and they are within normal limits." No response to email was given overnight and no phone call response either. Email response was given at 10:52am on 4/28/21 by Dr  who made clear that this is a mixed series and needs reporting to VAERS and should be noted on the vaccine card. No other actions were given.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: On 4/27/21, client was brought to vaccine site by case manager, who stated that he is homeless and currently at an inpatient psychiatric facility awaiting placement and needed a COVID vaccine in order to get housing. Case manager assisted client fill out Vaccination Screening Form with client signing it. After reviewing answers to questions with client (client denied having been vaccinated previously), Moderna vaccine was administered at 14:45. Client was monitored for the required 15 minute observation, with no adverse effects and stated "I feel fine." Two hours later, after the close of the vaccine clinic, documentation of the vaccine discovered that a previous COVID vaccine dose had been documented on 2/03/21. ThThis dose is recorded as Pfizer 0.3mL EN5318 in the left deltoid at pharmacy. No follow-up dose was recorded, only one dose of Pfizer was recorded. Moderna dose given was recorded into system.  County health services agency vaccination unit was notified for guidance for client safety. Phone calls were not answered, so email was sent with my work cell phone listed. Inpatient facility where client is staying was notified of mixed dose and asked to monitor for any adverse effects. RN on unit stated, "He is sitting in the day room. I just spoke with him and he had no complaints. His vital signs were just taken and they are within normal limits." No response to email was given overnight and no phone call response either. Email response was given at 10:52am on 4/28/21 by Dr  who made clear that this is a mixed series and needs reporting to VAERS and should be noted on the vaccine card. No other actions were given.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deafness, Dizziness, Throat clearing, Throat tightness, Vomiting
Clinical narrative: 10 minutes after the shot:I started feeling dizzy and nauseous. Asked a person if I should tell someone there. She got a nurse. I told her how I felt. Then I couldn?t hear and felt faintish.  About five ladies helped me get down to the floor and my throat felt suddenly very swollen and I couldn?t breathe in air. I was trying very hard to breathe. I heard someone say to call 911 at one time. One lady instructed me about giving me an EpiPen shot in my right thigh. I felt like everything went black and dark as I slumped way down and then all of a sudden I could breathe and projectile vomited at the same time (I felt so sorry about that). They helped me with wet towels.  They found my husband in the parking lot (he drove me there).  The EMT came in, it seemed quickly. I think I heard they were there within 5 minutes.  The EMT said they would like to take me to the hospital to be observed. I said yes.  He said you said yes? I said yes.  The two EMTs helped put me on the gurney.  Everyone was so nice and caring. They strapped me in and put me in the ambulance. My husband was setup to follow us. I remember my hands shaking and that the EMT said it was from the adrenaline, that it could do that.  I started feeling dizzy and a little nauseous again and asked for a wet paper towel. But then I felt my throat started closing up again and I couldn?t breathe in air.  It was worse than the first time. The EMT gave me another EpiPen dosage and talked me through  it.  There was a time there when I sent my love to my husband and kids.  All of a sudden I could breathe.  My pulse went down to 40.  The EMT got me an ice pack for the back of my neck as I asked for it to be placed. The EMT put on oxygen. He tried to put an IV into my right arm, then the left, then the right again.  He was finally able to get one in.  My veins kept collapsing. My husband knocked on the door and they let him know what had just happened as we were still in the parking lot at the vaccine site.  They pulled out to go to the hospital and brought me to the ER.  The ER staff watched over me for a few hours.  I was discharged a bit after 8:00 PM that same day.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Nausea, Pharyngeal swelling
Clinical narrative: 10 minutes after the shot:I started feeling dizzy and nauseous. Asked a person if I should tell someone there. She got a nurse. I told her how I felt. Then I couldn?t hear and felt faintish.  About five ladies helped me get down to the floor and my throat felt suddenly very swollen and I couldn?t breathe in air. I was trying very hard to breathe. I heard someone say to call 911 at one time. One lady instructed me about giving me an EpiPen shot in my right thigh. I felt like everything went black and dark as I slumped way down and then all of a sudden I could breathe and projectile vomited at the same time (I felt so sorry about that). They helped me with wet towels.  They found my husband in the parking lot (he drove me there).  The EMT came in, it seemed quickly. I think I heard they were there within 5 minutes.  The EMT said they would like to take me to the hospital to be observed. I said yes.  He said you said yes? I said yes.  The two EMTs helped put me on the gurney.  Everyone was so nice and caring. They strapped me in and put me in the ambulance. My husband was setup to follow us. I remember my hands shaking and that the EMT said it was from the adrenaline, that it could do that.  I started feeling dizzy and a little nauseous again and asked for a wet paper towel. But then I felt my throat started closing up again and I couldn?t breathe in air.  It was worse than the first time. The EMT gave me another EpiPen dosage and talked me through  it.  There was a time there when I sent my love to my husband and kids.  All of a sudden I could breathe.  My pulse went down to 40.  The EMT got me an ice pack for the back of my neck as I asked for it to be placed. The EMT put on oxygen. He tried to put an IV into my right arm, then the left, then the right again.  He was finally able to get one in.  My veins kept collapsing. My husband knocked on the door and they let him know what had just happened as we were still in the parking lot at the vaccine site.  They pulled out to go to the hospital and brought me to the ER.  The ER staff watched over me for a few hours.  I was discharged a bit after 8:00 PM that same day.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, C-reactive protein increased, Haemoglobin decreased, Musculoskeletal stiffness, Neck pain
Clinical narrative: Three days after the injection, I experienced severe muscle pain in my shoulders, thighs and around my hips. I took Tylenol for two weeks and when pains persisted, I went to urgent care. Blood was taken and it showed there was no infection, but the 3 markers for inflammation were high. I was told to wait another week to see if the pain passed. They did not, so I went to my doctor and he gave me a 10 day regime of Prednisone. After 10 days, the pains returned. I went to another doctor and he diagnosed that I had Polymyalgia Rheumatica. He believes the Covid vaccine kicked-off this condition. I am now on a regime of slowly reduced doses of Prednisone which could go on for 6 months to a year.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pelvic girdle pain, Polymyalgia rheumatica, Red blood cell sedimentation rate increased
Clinical narrative: Three days after the injection, I experienced severe muscle pain in my shoulders, thighs and around my hips. I took Tylenol for two weeks and when pains persisted, I went to urgent care. Blood was taken and it showed there was no infection, but the 3 markers for inflammation were high. I was told to wait another week to see if the pain passed. They did not, so I went to my doctor and he gave me a 10 day regime of Prednisone. After 10 days, the pains returned. I went to another doctor and he diagnosed that I had Polymyalgia Rheumatica. He believes the Covid vaccine kicked-off this condition. I am now on a regime of slowly reduced doses of Prednisone which could go on for 6 months to a year.